These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 29524445

  • 1. Favipiravir as a potential countermeasure against neglected and emerging RNA viruses.
    Delang L, Abdelnabi R, Neyts J.
    Antiviral Res; 2018 May; 153():85-94. PubMed ID: 29524445
    [Abstract] [Full Text] [Related]

  • 2. Understanding the Mechanism of the Broad-Spectrum Antiviral Activity of Favipiravir (T-705): Key Role of the F1 Motif of the Viral Polymerase.
    Abdelnabi R, Morais ATS, Leyssen P, Imbert I, Beaucourt S, Blanc H, Froeyen M, Vignuzzi M, Canard B, Neyts J, Delang L.
    J Virol; 2017 Jun 15; 91(12):. PubMed ID: 28381577
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Favipiravir, an anti-influenza drug against life-threatening RNA virus infections.
    Shiraki K, Daikoku T.
    Pharmacol Ther; 2020 May 15; 209():107512. PubMed ID: 32097670
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques.
    Guedj J, Piorkowski G, Jacquot F, Madelain V, Nguyen THT, Rodallec A, Gunther S, Carbonnelle C, Mentré F, Raoul H, de Lamballerie X.
    PLoS Med; 2018 Mar 15; 15(3):e1002535. PubMed ID: 29584730
    [Abstract] [Full Text] [Related]

  • 11. Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical Trials.
    Madelain V, Mentré F, Baize S, Anglaret X, Laouénan C, Oestereich L, Nguyen THT, Malvy D, Piorkowski G, Graw F, Günther S, Raoul H, de Lamballerie X, Guedj J.
    CPT Pharmacometrics Syst Pharmacol; 2020 May 15; 9(5):258-271. PubMed ID: 32198838
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Extinction of West Nile Virus by Favipiravir through Lethal Mutagenesis.
    Escribano-Romero E, Jiménez de Oya N, Domingo E, Saiz JC.
    Antimicrob Agents Chemother; 2017 Nov 15; 61(11):. PubMed ID: 28848019
    [Abstract] [Full Text] [Related]

  • 17. Successful treatment of Marburg virus with orally administrated T-705 (Favipiravir) in a mouse model.
    Zhu W, Zhang Z, He S, Wong G, Banadyga L, Qiu X.
    Antiviral Res; 2018 Mar 15; 151():39-49. PubMed ID: 29369776
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.